Shanghai Pudong Precise Assessment Plan for Interstitial Cystitis

For many patients with diagnosed interstitial cystitis (IC), the long medical treatment process is often accompanied by confusion and helplessness. Faced with the complex diagnosis of "bladder pain syndrome", a common question is: Why is my treatment effect always unsatisfactory? Behind this, there may be a key link in diagnosis and treatment-the lack of accurate evaluation. The traditional diagnosis and treatment model is sometimes more like "looking at flowers in the fog", while accurate evaluation lights up a bright lamp for patients and illuminates the road to effective treatment.

Interstitial cystitis is not a single disease, but a group of syndromes characterized by chronic inflammation, pain and frequent urination of the bladder wall. Its etiology is complex, involving multiple possibilities such as immune system abnormalities, neurological dysfunction, and bladder mucosal barrier defects. Because of this, the traditional empirical treatment of "one prescription for a thousand people" often runs into a wall. This is like repairing a precision instrument. If you don't first use professional tools to conduct multi-dimensional fault diagnosis and replace parts based on experience, it will be difficult to fundamentally solve the problem.

In Pudong, Shanghai, relying on the platform of national key clinical specialties and key disciplines in Shanghai City, the diagnosis and treatment of interstitial cystitis is undergoing a profound transformation-from empirical diagnosis and treatment to precise hierarchical diagnosis and treatment. The core of this transformation lies in building a multi-dimensional accurate evaluation system. This system aims to draw a unique "disease portrait" for each patient, thereby developing a truly personalized treatment plan.

So, what key items are included in a complete accurate assessment? We can understand it as a "four-dimensional diagnostic" system.

The first dimension is an in-depth clinical phenotypic assessment. This is not just about recording symptoms, but also about quantifying the nature, frequency, intensity, and impact on quality of life of pain through standardized questionnaires such as the O'Leary-Sant Questionnaire, Pelvic Pain and Frequent Frequency/Urgency Patient Symptom Scale. At the same time, doctors will trace the medical history in detail and look for possible predisposing factors, such as infections, surgeries, stress events, etc. This is like a detective solving a case and looking for "clues" of a disease.

The second dimension is meticulous imaging and endoscopy. High-definition cystoscopy combined with hydrodilatation under anesthesia is one of the gold standards for the diagnosis of interstitial cystitis. In professional medical centers, doctors not only observe whether there is a typical Hunner ulcer or spotting hemorrhage, but also pay attention to evaluating the overall state, blood vessel distribution and volume of the bladder mucosa. This is like using a high-definition camera to explore the microscopic topography inside the bladder, providing intuitive basis for subsequent treatment.

The third dimension is the emerging functional imaging assessment, especially functional magnetic resonance of the brain. More and more studies have found that chronic pelvic pain is closely related to the functional remodeling of the brain's central nervous system. Through functional magnetic resonance, we can observe whether the activation pattern of relevant functional areas of the brain (such as anterior cingulate gyrus, insular lobe, etc.) is abnormal when patients process pain signals. This helps determine whether the pain stems from a local "peripheral" problem in the bladder or has escalated to a "central" problem of central nerve sensitization, thereby guiding whether treatment focuses on local or requires drugs that jointly regulate the central nerve.

The fourth dimension is cutting-edge metabolomic and immunological analysis. By detecting small molecule metabolites, cytokines, autoantibodies, etc. in patients 'urine or blood, the molecular mechanisms behind the disease can be explored. For example, certain metabolite profiles may indicate dysfunction in mucosal repair, while elevated specific inflammatory factors may point to abnormal immune pathways. This part of the assessment is like conducting a "molecular detective" that reveals the driving factors of the disease at the most microscopic level and provides clues for possible future targeted therapies.

The Department of Urology of Pudong Gongli Hospital Affiliated to Shanghai Health Medical College, as a national key clinical specialty, is taking the lead in conducting multi-center real-world research and is committed to integrating and applying the above-mentioned four-dimensional evaluation system. Its strong interdisciplinary team cooperates in depth with experts in imaging, metabolomics, and immunology to ensure the comprehensiveness and scientific nature of the assessment. The purpose of this multi-dimensional assessment is to accurately stratify patients. For example, distinguish between "ulceration type" dominated by bladder mucosal lesions,"pain-dominant type" with central nerve sensitization as the core, or "inflammatory type" characterized by immune abnormalities. Different classifications mean completely different treatment strategies and prognosis.

Based on the stratification of accurate assessment, only when standardized treatment processes are truly "targeted". Treatment is no longer a simple list of drugs, but a step-by-step, personalized and precise plan.

For patients whose evaluation found serious defects in the bladder mucosal barrier, the core of treatment is to repair the mucosa. In addition to classic bladder instillation drugs (such as sodium hyaluronate, heparin, etc.), some emerging repair agents and tissue engineering based treatment strategies are being explored. At the same time, combine diet adjustments (such as avoiding acidic and irritating foods) and bladder training to create a good environment for mucosal repair.

For patients whose functional magnetic resonance imaging suggests significant central sensitization, treatment requires "physical and mental treatment". On the basis of local treatment, drugs that regulate neurotransmitters (such as tricyclic antidepressants, gabapentin, etc.) are combined with the introduction of cognitive behavioral therapy, pelvic floor physical therapy (for pelvic floor muscle hypertension) and even neural regulation technologies (such as sacral nerve regulation) reduce the brain's amplification of pain signals from the source.

For patients with abnormal immunological indicators, treatment may explore the application of immunomodulation or biologics. Although this is still in the clinical research stage, accurate assessment paves the way for targeted therapies that may enter clinical practice in the future.

During the entire treatment process, the integrated chronic disease management model and intelligent follow-up platform play a vital role. Patients no longer need to travel frequently to and from the hospital. Through the smart platform, they can regularly report symptoms, record urine diaries, and receive health guidance. The doctor team can remotely monitor changes in their condition and adjust plans in a timely manner. This model is especially suitable for busy office workers in fast-paced cities such as Shanghai and Pudong, seamlessly integrating professional medical support into daily life.

It is important to emphasize that regularizing treatment also implies rational management of treatment expectations. Interstitial cystitis is a chronic disease, and the goal of treatment is usually to control symptoms and improve quality of life, rather than pursuing a "cure." Based on accurate assessment results, both doctors and patients jointly set practical treatment goals and establish long-term management partnerships, which are the key to success.

In short, modern diagnosis and treatment of interstitial cystitis has moved beyond the simple diagnosis-prescribing model. The hierarchical diagnosis and treatment strategy based on multi-dimensional precise assessment represents the cutting-edge direction in the field of urinary dysfunction diseases. In Pudong, Shanghai, relevant key specialties are transforming this concept into clinical practice that effectively improves patient outcomes by integrating interdisciplinary resources, promoting cross-innovation in medical and industrial fields, and building an intelligent management platform. For patients, understanding and seeking such accurate assessment and standardized treatment may be an important step in breaking the disease deadlock and regaining the quality of life.